729094

Poly(ethylene glycol) diacrylate

average Mn 10,000, acrylate, MEHQ as inhibitor (may contain)

Manufacturer: Sigma Aldrich

CAS Number: 26570-48-9

Synonym(S): Polyethylene glycol, PEG diacrylate

Select a Size

Pack Size SKU Availability Price
1 G 729094-1-G In Stock ₹ 11,233.20

729094 - 1 G

₹ 11,233.20

In Stock

Quantity

1

Base Price: ₹ 11,233.20

GST (18%): ₹ 2,021.976

Total Price: ₹ 13,255.176

product name

Poly(ethylene glycol) diacrylate, average Mn 10,000, contains MEHQ as inhibitor

form

solid

Quality Level

100

mol wt

average Mn 10,000

contains

MEHQ as inhibitor≤1,500 ppm MEHQ as inhibitor (may contain)

reaction suitability

reagent type: cross-linking reagentreaction type: Polymerization Reactions

transition temp

Tm 60-64 °C

Mw/Mn

<1.1

Ω-end

acrylate

α-end

acrylate

Related Products

Img

Sigma Aldrich

729086

average Mn 1,000, acrylate, MEHQ as...

Img

Sigma Aldrich

725684

average MN 10,000, cross-linking re...

Img

Sigma Aldrich

725692

average MN 20,000, cross-linking re...

Img

Sigma Aldrich

701963

average Mn 6,000, acrylate, ≤1,500 ...

Img

Sigma Aldrich

701971

average Mn 2,000, acrylate, MEHQ as...

Img

Sigma Aldrich

730270

average Mn 2,000, acrylate, methoxy...

Img

Sigma Aldrich

907049

average MN 4,000 (by NMR), average ...

Img

Sigma Aldrich

906859

average MN 1,000 (by NMR), cross-li...

Description

  • Application: 3D Bioprinting of Hydrogels: This study explores the formulation of PEGDA-based hydrogels for 3D bioprinting, focusing on rheological properties and structural fidelity, particularly relevant for tissue engineering applications (Wu et al., 2018). Sustained Ocular Drug Delivery: Investigates the delivery of small and large drug molecules using PEGDA implants, highlighting the implications for sustained drug release in ocular therapies (McAvoy et al., 2018). Tissue Engineering Scaffolds: Evaluates PEGDA-polycaprolactone scaffolds for tissue engineering, emphasizing the control over porosity and its importance for regenerative medicine applications (Kotturi et al., 2017). Photocrosslinked Hydrogel Implants: Focuses on photocrosslinked PEGDA implants for drug delivery, providing insights into the design of drug delivery systems that can be finely tuned for specific therapeutic needs (Qin et al., 2015). Hydrogel-Based Artificial Muscles: Characterizes PEGDA/acrylic acid hydrogels optimized for use as artificial muscles, highlighting their potential in biomedical engineering and smart materials (Browe et al., 2017).
  • Preparation Note: Synthesized with an initial concentration of ≤1,500 ppm MEHQ

SAFETY INFORMATION

Pictograms

GHS05,GHS07

Signal Word

Danger

Hazard Statements

H315,H317,H318

Precautionary Statements

P261 - P264 - P272 - P280 - P302 + P352 - P305 + P351 + P338

Hazard Classifications

Eye Dam. 1 - Skin Irrit. 2 - Skin Sens. 1

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable